Joshua S. Boger, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 6,500 shares at $81.85 ($515K) on 2016-10-26, disclosed to the SEC on 2016-10-28.
Scheduled sale ($515k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.80 | 2,000 | $156K | 30.2% |
| 2 | $78.92 | 1,700 | $134K | 26.0% |
| 3 | $80.06 | 1,100 | $88K | 17.1% |
| 4 | $80.74 | 1,600 | $129K | 25.1% |
| 5 | $81.85 | 100 | $8K | 1.6% |
| Total | $79.26 avg | 6,500 |
| $515K |
| 100% |
| Filing → |
| VRTX | SELL | 2017-01-06 | $501K | — | Filing → |
| VRTX | SELL | 2017-01-03 | $483K | — | Filing → |
| VRTX | SELL | 2016-12-22 | $482K | — | Filing → |